Product Information
CLINDAMYCIN HCL 150 MG CAPSULE is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1072 per EA under NDC 68462014301. Its NADAC has been published 160 times since Jun 7, 2023.
Strength
150 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462014301
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLINDAMYCIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216957On Market Since
3/10/2023
Pharmacological Classes
Price Statistics
The NADAC for CLINDAMYCIN HCL 150 MG CAPSULE has been published 160 times since Jun 7, 2023, and over the history we have for it it has declined 10.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1072 per EA |
|---|---|
| All-time high | $0.1201 (Jun 14, 2023) |
| All-time low | $0.0760 (Nov 20, 2024) |
| 52-week high | $0.1097 |
| 52-week low | $0.0979 |
| Median price | $0.1032 |
| Average price | $0.0997 |
| Largest weekly change | +26.2% (Aug 21, 2024) |
| Weeks tracked | 160 |
| Tracking since | Jun 7, 2023 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLINDAMYCIN HCL 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN HCL 150 MG CAPSULE, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1072 per EA (NDC 68462014301), effective Jun 24, 2026.
How has the price of CLINDAMYCIN HCL 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CLINDAMYCIN HCL 150 MG CAPSULE has declined 10.8%. It has been tracked across 160 weekly CMS publications since Jun 7, 2023.
What are the highest and lowest recorded NADAC prices for CLINDAMYCIN HCL 150 MG CAPSULE?
Since Jun 7, 2023, the NADAC for CLINDAMYCIN HCL 150 MG CAPSULE has ranged from a low of $0.0760 (Nov 20, 2024) to a high of $0.1201 (Jun 14, 2023), with a median of $0.1032 per EA.
Are there cheaper alternatives to CLINDAMYCIN HCL 150 MG CAPSULE?
4 NADAC-published products share the same active ingredient, strength, and dosage form as CLINDAMYCIN HCL 150 MG CAPSULE, but none are currently priced below it.
Who manufactures CLINDAMYCIN HCL 150 MG CAPSULE?
CLINDAMYCIN HCL 150 MG CAPSULE (NDC 68462014301) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification